Delivery Order SPE2DB20D1109-SPE2DB25FM96C
Award Date 10/21/24
Potential Completion Date 10/22/24
Potential Value $2.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Pulmozyme 1 mg/ml ampuls (2.5 ml) to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,410.99, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and has a completion date of July 30, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
- This federal contract award, valued at $68,193.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp for the supply of Pulmozyme 1 mg/ml ampules (2.5 ml). The contract has a firm fixed price and an ultimate completion date of August 14, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order under its Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of Pulmozyme 1 mg/ml ampul 2.5 ml, a specialty medication. The $5,231 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 28, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,001.35, is for the delivery of Pulmozyme 1 mg/ml ampuls with a 2.5 ml dosage. The contract has a completion date of February 16, 2024 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $13,357.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award is for a delivery order to supply Pulmozyme 1 mg/ml ampul 2.5 ml, a medication used to treat cystic fibrosis. The contract has a firm fixed price and a performance period ending on April 30, 2025. This award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,849.83, is for the delivery of Pulmozyme 1 mg/ml ampul 2.5 ml, a medication used to treat cystic fibrosis. The contract has a period of performance through February 19, 2025 and is structured as a firm fixed-price delivery order. This award is part of Amerisourcebergen's...
- This federal contract award, valued at $5,736.05, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the prescription drug Pulmozyme (1 mg/ml ampul, 2.5 ml) and has a completion date of May 6, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $61,378.77, is for the delivery of Pulmozyme 1 mg/ml ampules with a completion date of February 27, 2024. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen Drug Corp is a...
- The U.S. government awarded a $20,963.60 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which has no set-aside designation, is for the provision of Pulmozyme 1 mg/ml ampul 2.5 ml to the Department of Defense (DoD) and its Medical Supply Chain agency. Amerisourcebergen, a major pharmaceutical distributor, holds significant Indefinite Delivery Contracts (IDCs) with the Defense Logistics Agency (DLA) Troop Support Medical for up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,750.80 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...